A5090603161- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Pneumonia and Respiratory Infections
- Bacterial Infections and Vaccines
- Diphtheria, Corynebacterium, and Tetanus
- Monoclonal and Polyclonal Antibodies Research
- Historical Medical Research and Treatments
- COVID-19 epidemiological studies
- Pediatric health and respiratory diseases
- COVID-19 Impact on Reproduction
- Vaccine Coverage and Hesitancy
- Immune responses and vaccinations
- Influenza Virus Research Studies
- Human Health and Disease
Gabrichevsky Institute of Epidemiology and Microbiology
2019-2025
Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
2019
The novel coronavirus (SARS-CoV-2) pandemic, dubbed COVID-19, has become one of the most serious challenges for human populations in vast majority countries worldwide. Rapid spreading and increased mortality related to it required new approaches manage epidemic processes on a global scale. One such was based analyzing SARS-CoV-2 seroprevalence associated with COVID-19. Our aim summarize results assessing nucleocapsid antigen (Nc) residents from 26 regions Russian Federation, carried out...
Relevance . Although the incidence of Hib infection has decreased in last three decades, it is still significant. Even with appropriate treatment, case-fatality rate can be as high 5%. Up to 40% children may suffer lifelong complications. classified vaccine-preventable, WHO and CDC do not post annual information on their resources, unlike other vaccine-preventable infections. Therefore, an assessment global epidemic situation only based results studies conducted different countries....
The coronavirus disease pandemic (COVID-19) was announced by WHO in February 2020. In Moscow, the first case of detected on March 2, 2020 a man who arrived from Italy. Two weeks after case, there an exponential increase number cases. incidence peaked 19th week year, followed steady decline, lasting 16 weeks. Objective. To investigate level and structure population immunity to SARS-CoV-2 virus among Moscow against background COVID-19. Patients methods. study residents carried out period July...
The aim of the study is to summarize results a seroprevalence children SARS-CoV-3, obtained during implementation Rospotrebnadzor program assess NC antigen SARS-CoV-2 population 26 regions Russian Federation, conducted COVID-19 epidemic in 2020. Research methods: model territories Federation was carried out according unified methodology developed by with participation St. Petersburg Pasteur Institute Epidemiology and Microbiology. method provided for formation group volunteers federative...
A pandemic of the disease caused by SARS-CoV-2 virus (hereinafter referred to as COVID-19) was announced WHO in February 2020. In Moscow Region (MR), first case detected on March 7, 2020 a woman who arrived from Switzerland. Four weeks later, rapid rise began, peak which fell 20th week (May 11, – May 17, 2020), replaced gradual steady decline that lasted for 13 weeks. Objective. To determine level and structure population immunity among between June 22, July Patients methods. serological...
We evaluated humoral immunity (presence of specific IgM and IgG) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare professionals providing inpatient care for individuals with COVID-19. Objective. To detected measure the level anti-SARS-CoV-2 antibodies in to identify how many them contacted COVID-19 patients, including those who had asymptomatic or subclinical disease. Materials methods. Anti-SARS-CoV-2 were using enzyme-linked immunosorbent assay (ELISA)...
Objective: to study the seroprevalence of SARS-CoV-2 antibodies (AB) in children 2nd year COVID-19 pandemic Russia. Materials and methods: prospective cohort study. The research was conducted among 3670 aged 1 17 y/o from 26 modelling regions Russia (that have been participating earlier five stages seromonitoring during 2020-2021). serological testing carried out December, 2021. work according a unified methodology set by Russian Federal Service for Supervision Consumer Rights Protection...
The aim of the work was to assess effectiveness serodiagnosis pertussis in people over 50 who complained prolonged cough. study included 30 patients age applied consultative diagnostic center complaining a cough period from 2015 - 2020. Blood serum samples were investigated enzyme immunoassay with definition antitussive antibodies three classes IgM, IgG, IgA commercial test system RIDASCREEN (R-Biopharm AG, Germany). It found that individuals 50, IgM above threshold level not detected....